Management of vascular complications following transcatheter aortic valve implantation

Perrin, Nils
Ellenberger, Christoph
Licker, Marc
Hachulla, Anne-Lise
Cikirikcioglu, Mustafa
Frei, Angela
Roffi, Marco
Noble, Stéphane

Open link

Publication date

October 2015

DOI

10.1016/j.acvd.2015.03.007

Publisher

Elsevier Masson SAS.

Abstract

SummaryBackgroundVascular complications (VCs) after transcatheter aortic valve implantation (TAVI) are frequent and their management is challenging.AimTo report the incidence, predictors and management of VCs following percutaneous transfemoral TAVI (TF-TAVI) at a single centre.MethodsWe analyzed 102 consecutive patients who underwent percutaneous TF-TAVI between August 2008 and December 2013. All endpoints were evaluated at 30 days and 6 months according to Valve Academic Research Consortium-2 criteria. VC percutaneous treatment success was defined as residual stenosis<30%, absence of blood extravasation and absence of surgical or repeat endovascular intervention at 30 days.ResultsTwenty-two patients (22%) experienced VCs, including five p...